Si-bone, INC 10-Q quarterly reports

SI-BONE, Inc. announced a 15.2% increase in revenue for the second quarter of 2026, driven by strong procedural volume growth in the U.S. and expanding international sales.

SI-BONE, Inc. reported its first quarter 2026 financial results, showing an 11.2% increase in revenue to $52.6 million, driven by higher U.S. procedure volumes and expanded product adoption.

SI-BONE, Inc. reported a 20.6% increase in Q3 2025 revenue to $48.7 million and significantly reduced its net loss, driven by expanded product offerings and increased case volumes.

SI-BONE, Inc. reported a significant 21.7% increase in Q2 2025 revenue and a reduced net loss, driven by expanded product offerings and increased U.S. surgical volumes.

SI-BONE, Inc. announces a 25% increase in revenue for the first quarter of 2025, while navigating an ongoing investigation by the U.S. Department of Justice.

SI-BONE, Inc. announced its third-quarter 2024 financial results, highlighting a 19% increase in revenue compared to the same period last year.

SI-BONE, Inc. announced an 18% increase in revenue for the second quarter of 2024 compared to the same period last year, primarily driven by growth in U.S. sales.

SI-BONE, Inc. announced its first quarter 2024 financial results, highlighting a 16% increase in revenue compared to the same period last year, driven primarily by growth in U.S. sales.